GlassScriptPhysician profile
Fred S Grabiner
NPI 1962487496
$568.22
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $41.88.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $173.39 | 2019 | |
| Amgen INC. | $88.31 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.94 | 2019 | |
| Merck Sharp & Dohme LLC | $46.88 | 2019 | |
| Lupin INC. | $46.58 | 2019-2020 | |
| Coopersurgical, INC. | $40.53 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $26.19 | 2019 | |
| Novo Nordisk INC | $20.17 | 2019 | |
| Ferring Pharmaceuticals INC. | $19.33 | 2019 | |
| Dysis Medical, INC. | $16.20 | 2019 | |
| Hologic Sales and Service, LLC | $15.45 | 2019 | |
| Therapeuticsmd, INC. | $15.25 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Grabiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.